In this study, we aimed to identify an inducer capable of upregulating SVCT2 expression, thereby promoting high-dose intracellular AA uptake in low-SVCT2-expressing cancer cells to achieve enhanced anticancer effects. Here, SLC23A2 is linked to cancer.